Therapeutic implications of the metabolic changes associated with BRAF inhibition in melanoma

Loftus, Alexander W.; Zarei, Mehrdad; Kakish, Hanna; Hajihassani, Omid; Hue, Jonathan J.; Boutros, Christina; Graor, Hallie J.; Nakazzi, Faith; Bahlibi, Tsegaw; Winter, Jordan M.; Rothermel, Luke D.

doi:10.1016/j.ctrv.2024.102795

Cancer Treatment Reviews

2024

DOI: 10.1016/j.ctrv.2024.102795

|View full text |Cite

Therapeutic implications of the metabolic changes associated with BRAF inhibition in melanoma

Alexander W. Loftus,

Mehrdad Zarei,

Hanna Kakish

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Preprint1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 103 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Integrated bioinformatic analyses defined ALDH18A1 as key regulators in glutamine metabolism in lung adenocarcinoma

Ren,

Ge,

Yang

et al. 2024

Preprint

View full text Add to dashboard Cite

Glutamine metabolism is pivotal in cancer biology, profoundly influencing tumor growth, proliferation, and resistance to therapies. Cancer cells often exhibit an elevated dependence on glutamine for essential functions such as energy production, biosynthesis of macromolecules, and maintenance of redox balance. Moreover, altered glutamine metabolism can contribute to the formation of an immune-suppressive tumor microenvironment characterized by reduced immune cell infiltration and activity. In this study on lung adenocarcinoma, we used consensus clustering and applied 101 machine learning methods to systematically identify key genes associated with glutamine metabolism. This comprehensive approach yielded a refined understanding of how these metabolic pathways contribute to cancer progression and patient outcomes. Importantly, a robust risk model was constructed using these identified genes to predict overall survival in lung adenocarcinoma patients. This model not only enhances our ability to stratify patient risk but also provides potential targets for therapeutic intervention aimed at disrupting glutamine metabolism and sensitizing tumors to existing treatments. Such insights underscore the critical role of glutamine metabolism in cancer and highlight avenues for personalized medicine in oncology research.

show abstract

Integrated bioinformatic analyses defined ALDH18A1 as key regulators in glutamine metabolism in lung adenocarcinoma

Ren,

Ge,

Yang

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Therapeutic implications of the metabolic changes associated with BRAF inhibition in melanoma

Cited by 1 publication

References 103 publications

Integrated bioinformatic analyses defined ALDH18A1 as key regulators in glutamine metabolism in lung adenocarcinoma

Integrated bioinformatic analyses defined ALDH18A1 as key regulators in glutamine metabolism in lung adenocarcinoma

Contact Info

Product

Resources

About